Jim L. Allen serves as Executive at BioCardia, Inc., where they oversee executive responsibilities. Since joining the company, Jim L. Allen has executed 12 insider transactions totaling $300.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 3, 2024 involved receiving (via award) 50,000 shares valued at $150.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 3, 2024 | BCDA | $150.0K | Award | 50,000 | $3.00 | Discretionary |
| Jun 23, 2023 | BCDA;BCDAW | $150.3K | Award |
Jim L. Allen currently holds 109,661 shares of BioCardia, Inc. (BCDA;BCDAW), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jim L. Allen has been a net buyer of BCDA;BCDAW stock. They have purchased $300.0K and sold $0 worth of shares.
Jim L. Allen's most recent insider trade was on Sep 3, 2024, when they sold 50,000 shares at $3.00 per share.
Get notified when new Form 4 filings are submitted
| 64,212 |
| $2.34 |
| Discretionary |
| Dec 16, 2022 | BCDA;BCDAW | $250.0K | Award | 148,809 | $1.68 | Discretionary |
| Mar 31, 2021 | BCDA;BCDAW | $0 | Award | 2,520 | $N/A | Discretionary |
| Dec 31, 2020 | BCDA;BCDAW | $0 | Award | 2,734 | $N/A | Discretionary |
| Dec 31, 2020 | BCDA;BCDAW | $0 | Award | 2,800 | $N/A | Discretionary |
| Sep 30, 2020 | BCDA;BCDAW | $0 | Award | 2,734 | $N/A | Discretionary |
| Jun 30, 2020 | BCDA;BCDAW | $0 | Award | 2,734 | $N/A | Discretionary |
| Jun 19, 2020 | BCDA;BCDAW | $300.0K | Purchase | 142,850 | $2.10 | Discretionary |
| May 8, 2020 | BCDA;BCDAW | $0 | Award | 4,100 | $N/A | Discretionary |
| Apr 30, 2020 | BCDA;BCDAW | $0 | Award | 2,734 | $N/A | Discretionary |
| Apr 30, 2020 | BCDA;BCDAW | $0 | Award | 2,187 | $N/A | Discretionary |